开云app官网登录入口网页版-官方正版

#激酶#

224篇内容 | 3561人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2177529, encodeId=dc3d21e752961, content=<a href='/topic/show?id=0303e918842' target=_blank style='color:#2F92EE;'>#绿色荧光蛋白#</a> <a href='/topic/show?id=9c516685eea' target=_blank style='color:#2F92EE;'>#激酶#</a> <a href='/topic/show?id=2ae21092e170' target=_blank style='color:#2F92EE;'>#荧光团#</a>, objectTitle=Cell：新方法能够对活细胞内的动态信号网络进行成像观察, objectType=article, longId=805461, objectId=f8c9805461ba, topicUrl=null, isHasObj=0, objectCover=https://msimg.bioon.com/bioon-com/20231216/1702709839423_2185383.png, objectUrl=/article/show_article.do?id=f8c9805461ba, replyNumber=0, likeNumber=43, createdTime=2023-12-27, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1496126, encodeId=e79a14961260e, content=<a href='/topic/show?id=9c516685eea' target=_blank style='color:#2F92EE;'>#激酶#</a>, objectTitle=JAHA：可溶性尿激酶纤溶酶原激活物受体与COVID-19患者静脉血栓栓塞的关系, objectType=article, longId=734844, objectId=961ee3484403, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=961ee3484403, replyNumber=0, likeNumber=98, createdTime=2022-08-06, rootId=0, userName=redcrab, userId=73449239400, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=961ee3484403, moduleTitle=JAHA：可溶性尿激酶纤溶酶原激活物受体与COVID-19患者静脉血栓栓塞的关系, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=961ee3484403)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496125, encodeId=38aa14961252c, content=<a href='/topic/show?id=9c516685eea' target=_blank style='color:#2F92EE;'>#激酶#</a>, objectTitle=Rheumatology：Janus激酶抑制剂和新型活动性疾病生物标记物在青少年皮肌炎中的长期随访结果, objectType=article, longId=734175, objectId=c505e341758a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c505e341758a, replyNumber=0, likeNumber=70, createdTime=2022-08-03, rootId=0, userName=redcrab, userId=73449239400, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c505e341758a, moduleTitle=Rheumatology：Janus激酶抑制剂和新型活动性疾病生物标记物在青少年皮肌炎中的长期随访结果, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=c505e341758a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496124, encodeId=bb0e1496124dd, content=<a href='/topic/show?id=9c516685eea' target=_blank style='color:#2F92EE;'>#激酶#</a>, objectTitle=新型 p38 丝裂原活化蛋白激酶抑制剂可逆转缺氧诱导的大鼠肺动脉高压, objectType=article, longId=733923, objectId=b021e339232f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b021e339232f, replyNumber=0, likeNumber=97, createdTime=2022-07-31, rootId=0, userName=redcrab, userId=73449239400, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b021e339232f, moduleTitle=新型 p38 丝裂原活化蛋白激酶抑制剂可逆转缺氧诱导的大鼠肺动脉高压, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=b021e339232f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496123, encodeId=3a621496123ee, content=<a href='/topic/show?id=9c516685eea' target=_blank style='color:#2F92EE;'>#激酶#</a>, objectTitle=Clin Cancer Res：抗PD-1抗体联合多激酶抑制剂治疗晚期胃癌, objectType=article, longId=729651, objectId=592de2965133, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=592de2965133, replyNumber=0, likeNumber=140, createdTime=2022-06-17, rootId=0, userName=redcrab, userId=73449239400, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=592de2965133, moduleTitle=Clin Cancer Res：抗PD-1抗体联合多激酶抑制剂治疗晚期胃癌, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=592de2965133)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496122, encodeId=b5441496122fe, content=<a href='/topic/show?id=9c516685eea' target=_blank style='color:#2F92EE;'>#激酶#</a>, objectTitle=HAEMATOLOGICA：慢性粒细胞白血病患者停用酪氨酸激酶抑制剂后的疼痛报告研究, objectType=article, longId=727689, objectId=c057e27689e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c057e27689e7, replyNumber=0, likeNumber=123, createdTime=2022-05-25, rootId=0, userName=redcrab, userId=73449239400, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c057e27689e7, moduleTitle=HAEMATOLOGICA：慢性粒细胞白血病患者停用酪氨酸激酶抑制剂后的疼痛报告研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=c057e27689e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496121, encodeId=3c0c149612127, content=<a href='/topic/show?id=9c516685eea' target=_blank style='color:#2F92EE;'>#激酶#</a>, objectTitle=AJH：使用基于布鲁顿酪氨酸激酶抑制剂的一线疗法治疗TP53改变的 CLL：回顾性分析, objectType=article, longId=727113, objectId=2ccae2711328, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2ccae2711328, replyNumber=0, likeNumber=136, createdTime=2022-05-18, rootId=0, userName=redcrab, userId=73449239400, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2ccae2711328, moduleTitle=AJH：使用基于布鲁顿酪氨酸激酶抑制剂的一线疗法治疗TP53改变的 CLL：回顾性分析, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=2ccae2711328)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496120, encodeId=8a65149612021, content=<a href='/topic/show?id=9c516685eea' target=_blank style='color:#2F92EE;'>#激酶#</a>, objectTitle=A&R：细胞周期蛋白依赖性激酶4/6抑制剂对系统性硬化小鼠模型皮肤纤维化的治疗作用, objectType=article, longId=727078, objectId=5e3fe2707805, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e3fe2707805, replyNumber=0, likeNumber=84, createdTime=2022-05-18, rootId=0, userName=redcrab, userId=73449239400, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e3fe2707805, moduleTitle=A&R：细胞周期蛋白依赖性激酶4/6抑制剂对系统性硬化小鼠模型皮肤纤维化的治疗作用, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=5e3fe2707805)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496119, encodeId=173c149611911, content=<a href='/topic/show?id=9c516685eea' target=_blank style='color:#2F92EE;'>#激酶#</a>, objectTitle=A&R：CD163+ M2巨噬细胞通过Toll样受体7/IL-1受体相关激酶4/NF-κB信号通路促进IgG4相关疾病的纤维化, objectType=article, longId=726552, objectId=259ee265523c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=259ee265523c, replyNumber=0, likeNumber=96, createdTime=2022-05-12, rootId=0, userName=redcrab, userId=73449239400, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=259ee265523c, moduleTitle=A&R：CD163+ M2巨噬细胞通过Toll样受体7/IL-1受体相关激酶4/NF-κB信号通路促进IgG4相关疾病的纤维化, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=259ee265523c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496118, encodeId=bea914961182e, content=<a href='/topic/show?id=9c516685eea' target=_blank style='color:#2F92EE;'>#激酶#</a>, objectTitle= Ann Med ：用酪氨酸激酶抑制剂治疗的患有慢性期慢性粒细胞白血病的青少年和年轻人的结果, objectType=article, longId=725905, objectId=f05ce2590585, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f05ce2590585, replyNumber=0, likeNumber=95, createdTime=2022-05-02, rootId=0, userName=redcrab, userId=73449239400, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f05ce2590585, moduleTitle= Ann Med ：用酪氨酸激酶抑制剂治疗的患有慢性期慢性粒细胞白血病的青少年和年轻人的结果, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=f05ce2590585)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496117, encodeId=7452149611ecd, content=<a href='/topic/show?id=9c516685eea' target=_blank style='color:#2F92EE;'>#激酶#</a>, objectTitle=NEJM：Mitapivat治疗丙酮酸激酶缺乏症的疗效（ACTIVATE试验）, objectType=article, longId=724343, objectId=28e9e2434333, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28e9e2434333, replyNumber=0, likeNumber=73, createdTime=2022-04-17, rootId=0, userName=redcrab, userId=73449239400, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28e9e2434333, moduleTitle=NEJM：Mitapivat治疗丙酮酸激酶缺乏症的疗效（ACTIVATE试验）, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=28e9e2434333)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496127, encodeId=bce1149612ea7, content=<a href='/topic/show?id=9c516685eea' target=_blank style='color:#2F92EE;'>#激酶#</a>, objectTitle=Leuk Lymphoma：肌酸激酶升高与慢性粒细胞白血病临床结果的关联：一项回顾性队列研究。, objectType=article, longId=301364, objectId=3bcb3013643d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3bcb3013643d, replyNumber=0, likeNumber=103, createdTime=2022-03-23, rootId=0, userName=redcrab, userId=73449239400, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3bcb3013643d, moduleTitle=Leuk Lymphoma：肌酸激酶升高与慢性粒细胞白血病临床结果的关联：一项回顾性队列研究。, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=3bcb3013643d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496116, encodeId=a5a3149611688, content=<a href='/topic/show?id=9c516685eea' target=_blank style='color:#2F92EE;'>#激酶#</a>, objectTitle=Arthritis：白介素1受体相关激酶4抑制剂PF-06650833阻断风湿病临床前模型研究, objectType=article, longId=301324, objectId=195d301324f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=195d301324f5, replyNumber=0, likeNumber=78, createdTime=2022-03-23, rootId=0, userName=redcrab, userId=73449239400, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=195d301324f5, moduleTitle=Arthritis：白介素1受体相关激酶4抑制剂PF-06650833阻断风湿病临床前模型研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=195d301324f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496115, encodeId=ce05149611580, content=<a href='/topic/show?id=9c516685eea' target=_blank style='color:#2F92EE;'>#激酶#</a>, objectTitle=Arthritis Rheumatol：Bruton‘s酪氨酸激酶抑制剂Fenebrutinib治疗系统性红斑狼疮的疗效、安全性和药效学效应研究, objectType=article, longId=301207, objectId=11cf30120ed4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11cf30120ed4, replyNumber=0, likeNumber=124, createdTime=2022-03-21, rootId=0, userName=redcrab, userId=73449239400, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11cf30120ed4, moduleTitle=Arthritis Rheumatol：Bruton‘s酪氨酸激酶抑制剂Fenebrutinib治疗系统性红斑狼疮的疗效、安全性和药效学效应研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=11cf30120ed4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496114, encodeId=50e414961146c, content=<a href='/topic/show?id=9c516685eea' target=_blank style='color:#2F92EE;'>#激酶#</a>, objectTitle=JAHA：肌酸激酶与缺血性卒中或短暂性脑缺血发作患者的功能结局相关, objectType=article, longId=300122, objectId=3018300122f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3018300122f4, replyNumber=0, likeNumber=64, createdTime=2022-03-07, rootId=0, userName=redcrab, userId=73449239400, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3018300122f4, moduleTitle=JAHA：肌酸激酶与缺血性卒中或短暂性脑缺血发作患者的功能结局相关, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=3018300122f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496113, encodeId=687f149611371, content=<a href='/topic/show?id=9c516685eea' target=_blank style='color:#2F92EE;'>#激酶#</a>, objectTitle=Cancers：中性粒细胞胞外陷阱在慢性粒细胞白血病中增加，并且受酪氨酸激酶抑制剂的不同影响 , objectType=article, longId=293968, objectId=658129396889, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=658129396889, replyNumber=0, likeNumber=79, createdTime=2022-01-15, rootId=0, userName=redcrab, userId=73449239400, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=658129396889, moduleTitle=Cancers：中性粒细胞胞外陷阱在慢性粒细胞白血病中增加，并且受酪氨酸激酶抑制剂的不同影响 , moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=658129396889)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496112, encodeId=0d1b149611291, content=<a href='/topic/show?id=9c516685eea' target=_blank style='color:#2F92EE;'>#激酶#</a>, objectTitle=Leuk Lymphoma：帕纳替尼与其他酪氨酸激酶抑制剂作为美国慢性粒细胞白血病患者二线治疗的安全性和成本效益, objectType=article, longId=221252, objectId=69a622125247, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69a622125247, replyNumber=0, likeNumber=64, createdTime=2021-12-01, rootId=0, userName=redcrab, userId=73449239400, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69a622125247, moduleTitle=Leuk Lymphoma：帕纳替尼与其他酪氨酸激酶抑制剂作为美国慢性粒细胞白血病患者二线治疗的安全性和成本效益, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=69a622125247)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496111, encodeId=0fe01496111fe, content=<a href='/topic/show?id=9c516685eea' target=_blank style='color:#2F92EE;'>#激酶#</a>, objectTitle=Clin Cancer Res：多受体酪氨酸激酶抑制剂卡博替尼单药治疗晚期软组织肉瘤的效果, objectType=article, longId=220644, objectId=1bac22064495, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1bac22064495, replyNumber=0, likeNumber=94, createdTime=2021-11-21, rootId=0, userName=redcrab, userId=73449239400, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1bac22064495, moduleTitle=Clin Cancer Res：多受体酪氨酸激酶抑制剂卡博替尼单药治疗晚期软组织肉瘤的效果, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=1bac22064495)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496110, encodeId=6b2a149611059, content=<a href='/topic/show?id=9c516685eea' target=_blank style='color:#2F92EE;'>#激酶#</a>, objectTitle=Lancet Neurol：难分伯仲——非免疫原性重组葡激酶与阿尔替普酶治疗急性缺血性卒中患者的比较(FRIDA), objectType=article, longId=219166, objectId=7d30219166f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d30219166f5, replyNumber=0, likeNumber=87, createdTime=2021-10-25, rootId=0, userName=redcrab, userId=73449239400, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d30219166f5, moduleTitle=Lancet Neurol：难分伯仲——非免疫原性重组葡激酶与阿尔替普酶治疗急性缺血性卒中患者的比较(FRIDA), moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=7d30219166f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496109, encodeId=c3ed149610908, content=<a href='/topic/show?id=9c516685eea' target=_blank style='color:#2F92EE;'>#激酶#</a>, objectTitle=Mov Disord：服用磷酸甘油酸激酶1激活剂，与帕金森病的发病率有何关系？, objectType=article, longId=215453, objectId=e684215453b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e684215453b7, replyNumber=0, likeNumber=81, createdTime=2021-08-09, rootId=0, userName=redcrab, userId=73449239400, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e684215453b7, moduleTitle=Mov Disord：服用磷酸甘油酸激酶1激活剂，与帕金森病的发病率有何关系？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e684215453b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

激酶

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#绿色荧光蛋白# #激酶# #荧光团#

2023-12-27发表于上海

redcrab (审核中...)

前往app查看评论内容

#激酶#

JAHA：可溶性尿激酶纤溶酶原激活物受体与COVID-19患者静脉血栓栓塞的关系

2022-08-06

redcrab (审核中...)

前往app查看评论内容

#激酶#

Rheumatology：Janus激酶抑制剂和新型活动性疾病生物标记物在青少年皮肌炎中的长期随访结果

2022-08-03

redcrab (审核中...)

前往app查看评论内容

#激酶#

新型 p38 丝裂原活化蛋白激酶抑制剂可逆转缺氧诱导的大鼠肺动脉高压

2022-07-31

redcrab (审核中...)

前往app查看评论内容

#激酶#

Clin Cancer Res：抗PD-1抗体联合多激酶抑制剂治疗晚期胃癌

2022-06-17

redcrab (审核中...)

前往app查看评论内容

#激酶#

HAEMATOLOGICA：慢性粒细胞白血病患者停用酪氨酸激酶抑制剂后的疼痛报告研究

2022-05-25

redcrab (审核中...)

前往app查看评论内容

#激酶#

AJH：使用基于布鲁顿酪氨酸激酶抑制剂的一线疗法治疗TP53改变的 CLL：回顾性分析

2022-05-18

redcrab (审核中...)

前往app查看评论内容

#激酶#

A&R：细胞周期蛋白依赖性激酶4/6抑制剂对系统性硬化小鼠模型皮肤纤维化的治疗作用

2022-05-18

redcrab (审核中...)

前往app查看评论内容

#激酶#

A&R：CD163+ M2巨噬细胞通过Toll样受体7/IL-1受体相关激酶4/NF-κB信号通路促进IgG4相关疾病的纤维化

2022-05-12

redcrab (审核中...)

前往app查看评论内容

#激酶#

Ann Med ：用酪氨酸激酶抑制剂治疗的患有慢性期慢性粒细胞白血病的青少年和年轻人的结果

2022-05-02

redcrab (审核中...)

前往app查看评论内容

#激酶#

NEJM：Mitapivat治疗丙酮酸激酶缺乏症的疗效（ACTIVATE试验）

2022-04-17

redcrab (审核中...)

前往app查看评论内容

#激酶#

Leuk Lymphoma：肌酸激酶升高与慢性粒细胞白血病临床结果的关联：一项回顾性队列研究。

2022-03-23

redcrab (审核中...)

前往app查看评论内容

#激酶#

Arthritis：白介素1受体相关激酶4抑制剂PF-06650833阻断风湿病临床前模型研究

2022-03-23

redcrab (审核中...)

前往app查看评论内容

#激酶#

Arthritis Rheumatol：Bruton‘s酪氨酸激酶抑制剂Fenebrutinib治疗系统性红斑狼疮的疗效、安全性和药效学效应研究

2022-03-21

redcrab (审核中...)

前往app查看评论内容

#激酶#

JAHA：肌酸激酶与缺血性卒中或短暂性脑缺血发作患者的功能结局相关

2022-03-07

redcrab (审核中...)

前往app查看评论内容

#激酶#

Cancers：中性粒细胞胞外陷阱在慢性粒细胞白血病中增加，并且受酪氨酸激酶抑制剂的不同影响

2022-01-15

redcrab (审核中...)

前往app查看评论内容

#激酶#

Leuk Lymphoma：帕纳替尼与其他酪氨酸激酶抑制剂作为美国慢性粒细胞白血病患者二线治疗的安全性和成本效益

2021-12-01

redcrab (审核中...)

前往app查看评论内容

#激酶#

Clin Cancer Res：多受体酪氨酸激酶抑制剂卡博替尼单药治疗晚期软组织肉瘤的效果

2021-11-21

redcrab (审核中...)

前往app查看评论内容

#激酶#

Lancet Neurol：难分伯仲——非免疫原性重组葡激酶与阿尔替普酶治疗急性缺血性卒中患者的比较(FRIDA)

2021-10-25

redcrab (审核中...)

前往app查看评论内容

#激酶#

Mov Disord：服用磷酸甘油酸激酶1激活剂，与帕金森病的发病率有何关系？

2021-08-09

科室
- - 订阅+
  - 更多科室
工具
服务